33
Pfizer plans to outsource production of some of its drug portfolio to make way for a rapidly growing vaccine manufacturing effort, the company said Monday.
The drugmaker will lean on its 200-strong network of contractors as part of a plan to “build a robust U.S.-based supply chain as well as one based in Europe,” a Pfizer spokesperson said.
Pfizer has dedicated enormous resources to churning out hundreds of millions of doses of a possible coronavirus vaccine.
The drugmaker will lean on its 200-strong network of contractors as part of a plan to “build a robust U.S.-based supply chain as well as one based in Europe,” a Pfizer spokesperson said.
